ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

The foundational paradox and its initial articulation emerged from a dialogue between Joe Nalven — cultural anthropologist — ...

Digital transformation has created vast new opportunities. But that didn’t mean getting rid of everything we already had.

From designing algorithms to analyzing their efficiency, understanding these core concepts is key to solving problems in computer science. Time and space complexity guide us in choosing the best ...

In times when knowledge is stored and remixed as data, the tradition of storytelling still holds its own. The use of ...

In the late 1990s, search engines struggled with low-quality information. Larry Page and Sergey Brin developed a new approach ...

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...

A viral r/ChatGPT post pointing out the ubiquity of AI-generated content turned out to be AI-generated itself, drawing over 9 ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than ...

Michael Schmidt, CFA, is a staff member of FINRA's Dispute Resolution Board with 20+ years of experience in the financial market. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive ...